Skip to content
The Policy VaultThe Policy Vault

aprepitantCareFirst (Caremark)

Prevention of postoperative nausea and vomiting

Initial criteria

  • The request is NOT for Varubi (rolapitant)
  • The requested drug will be used in combination with other antiemetic agents
  • For postoperative nausea and vomiting, the request is for aprepitant capsules

Approval duration

6 months